BAIN CAPITAL INVESTORS LLC Long-Term Concentrated

CIK: 0001040508 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 14, 2022

Total Value ($000): $4,139,825 (100.0% shares, 0.0% debt)

Holdings (5)

— CEREVEL THERAPEUTICS HLDNG I 41.4%

Value ($000) $1,713,470 Shares 60,632,356 Est. Cost $16.58 Unrealized —

— DIVERSEY HLDGS LTD 27.8%

Value ($000) $1,149,687 Shares 236,561,159 Est. Cost $14.71 Unrealized —

SGRY SURGERY PARTNERS INC 27.7%

Value ($000) $1,148,111 Shares 49,064,576 Est. Cost $32.73 Unrealized -2.4%

AVAH AVEANNA HEALTHCARE HLDGS INC 3.0%

Value ($000) $122,401 Shares 81,600,880 Est. Cost $11.86 Unrealized -82.7%

ADV ADVANTAGE SOLUTIONS INC 0.1%

Value ($000) $6,156 Shares 2,890,000 Est. Cost $10.52 Unrealized -64.9%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	CEREVEL THERAPEUTICS HLDNG I	60,632,356	$1,713,470	41.4%	$16.58	—	COM	15678U128
—	DIVERSEY HLDGS LTD	236,561,159	$1,149,687	27.8%	$14.71	—	ORD SHS	G28923103
SGRY	SURGERY PARTNERS INC	49,064,576	$1,148,111	27.7%	$32.73	-2.4%	COM	86881A100
AVAH	AVEANNA HEALTHCARE HLDGS INC	81,600,880	$122,401	3.0%	$11.86	-82.7%	COM	05356F105
ADV	ADVANTAGE SOLUTIONS INC	2,890,000	$6,156	0.1%	$10.52	-64.9%	COM CL A	00791N102